UBS Group AG - BRIACELL THERAPEUTICS CORP ownership

Back to all holdings Add to watchlist

BRIACELL THERAPEUTICS CORP's ticker is BCTXW and the CUSIP is 10778Y112. A total of 8 filers reported holding BRIACELL THERAPEUTICS CORP in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.1%.

Links
Filings
External links
Quarter-by-quarter ownership
UBS Group AG ownership history of BRIACELL THERAPEUTICS CORP
ValueSharesWeighting
Q3 2023$351
-88.2%
142
-90.1%
0.00%–
Q4 2022$2,968
-62.9%
1,441
-50.9%
0.00%–
Q3 2022$8,000
-38.5%
2,933
-42.2%
0.00%–
Q2 2022$13,000
+116.7%
5,073
+346.2%
0.00%–
Q1 2022$6,000
-40.0%
1,137
-45.4%
0.00%–
Q3 2021$10,000–2,082–0.00%–
 Download
Other shareholders
BRIACELL THERAPEUTICS CORP shareholders Q3 2022
NameSharesValueWeighting ↓
Privium Fund Management B.V. 122,084$361,3690.12%
K.J. Harrison & Partners Inc 170,750$505,4200.10%
Redmond Asset Management, LLC 150,000$426,0000.07%
ARMISTICE CAPITAL, LLC 375,001$1,110,0000.02%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
View complete list of BRIACELL THERAPEUTICS CORP shareholders